Related Experiment Video
Updated: Nov 9, 2025

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
Published on: April 7, 2015
Differences Between Pediatric Acute Myocarditis Related and Unrelated to SARS-CoV-2
Vladislav A Vukomanovic1,2, Stasa Krasic1, Sergej Prijic1,2
1From the Cardiology Department, Mother and Child Health Institute of Serbia, Belgrade, Serbia.
Insights
Children with acute myocarditis (AM) related to SARS-CoV-2 showed distinct symptoms and faster recovery. AM unrelated to SARS-CoV-2 was associated with more severe outcomes in pediatric patients.
Area of Science:
- Pediatric Cardiology
- Infectious Diseases
- Critical Care Medicine
Background:
- Acute myocarditis (AM) is myocardial inflammation.
- Distinguishing AM related to SARS-CoV-2 from other causes is crucial for pediatric care.
- COVID-19 has emerged as a significant factor in pediatric cardiovascular conditions.
Purpose of the Study:
- To conduct a comparative analysis of acute myocarditis (AM) in children.
- To identify differences between AM associated with SARS-CoV-2 and AM from other causes.
- To evaluate clinical presentation, laboratory findings, and outcomes in pediatric AM patients.
Main Methods:
- Retrospective study of pediatric patients diagnosed with AM between January 2018 and November 2020.
- Comparison of clinical characteristics, laboratory markers (cTnI, platelets, CRP, BNP), and treatment strategies.
- Analysis of patient outcomes, including adverse events and recovery of cardiac function.
Main Results:
- Seven of 24 pediatric patients had AM related to SARS-CoV-2, presenting with abdominal pain, headache, rash, and conjunctivitis.
- AM unrelated to SARS-CoV-2 was more frequently associated with fulminant myocarditis and adverse outcomes (e.g., death, dilated cardiomyopathy).
- SARS-CoV-2-related AM showed lower cTnI and platelets, higher CRP, shorter inotropic support duration, and faster left ventricle systolic function recovery.
Conclusions:
- Pediatric AM related to SARS-CoV-2 exhibits a distinct clinical profile, including a polymorphic presentation and higher CRP levels.
- Patients with SARS-CoV-2-associated AM experienced shorter inotropic drug requirements and demonstrated prompt recovery of left ventricular systolic function.
- AM unrelated to SARS-CoV-2 was linked to more frequent severe adverse outcomes in the pediatric population.
Background:
Acute myocarditis (AM) is defined as inflammation of the myocardium. The aim of our study is a comparative analysis of the differences between AM related and unrelated to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Methods:
The retrospective study included children with AM treated from January 2018 to November 2020.
Results:
The study included 24 patients; 7 of 24 had AM related to SARS-CoV-2 and they were older than 7. They were more likely to have abdominal pain (P = 0.014), headache (P = 0.003), cutaneous rash (P = 0.003), and conjunctivitis (P = 0.003), while fulminant myocarditis was commonly registered in AM unrelated to SARS-CoV-2 (P = 0.04). A multisystem inflammatory syndrome in children associated with COVID-19 was diagnosed in six adolescents. Patients with AM related SARS-CoV-2 had lower serum cardiac troponin I (cTnI) (P = 0.012), and platelets (P < 0.001), but had a higher C-reactive protein (CRP) value (P = 0.04), and N-terminal-pro hormone BNP in comparison to patients with AM unrelated to SARS-CoV-2. The patients with AM related to SARS-CoV-2 had significant reduction of CRP (P = 0.007). Inotropic drug support was used for shorter durations in patients with AM related to SARS-CoV-2, than in others (P = 0.02). Children with AM related to SARS-CoV-2 had significant improvement of left ventricle systolic function on the third day in hospital (P = 0.001). Patients with AM unrelated to SARS-CoV-2 AM had more frequent adverse outcomes (P = 0.04; three died and four dilated cardiomyopathy).
Conclusions:
In contrast to patients with AM unrelated to SARS-CoV-2, patients with AM related to SARS-CoV-2 had a higher CRP value, polymorphic clinical presentation, shorter durations of inotropic drugs use as well as prompt recovery of left ventricle systolic function.
More Related Videos
08:05Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
08:41Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis I: Introduction
Myocarditis III: Medical Management
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Cardiomyopathy I: Introduction and Classification
Pericarditis I: Introduction